GHK-Cu
Copper-binding tripeptide with skincare ubiquity and injectable research interest.
- Primary research area
- Skin / hair / tissue
- FDA status
- Cosmetic approval; injectable Category 2
- Last updated
- Apr 21, 2026
- Reviewed by
- Peptide Examiner editorial team
What it is
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) chelated to a copper ion (Cu²⁺). Discovered in human plasma in the 1970s, GHK-Cu is one of the most-studied peptides in dermatology and cosmetic science, with decades of topical-use data. It's a common ingredient in high-end skincare and hair-growth products and is FDA-permitted for topical cosmetic use. An injectable form has been marketed for research use but is currently on the FDA's Category 2 list (with a February 2026 HHS proposal to remove).
Mechanism of action
GHK-Cu's mechanism operates at multiple levels relevant to skin and tissue: it stimulates collagen synthesis and inhibits collagen degradation in dermal fibroblasts, modulates wound healing signaling via TGF-β and related pathways, acts as a copper-delivery vehicle (copper is a cofactor for lysyl oxidase, critical to collagen cross-linking), suppresses fibrosis, and has antioxidant effects through copper redox chemistry. Bioinformatic analyses have cataloged GHK-Cu as a modulator of roughly 30% of human gene expression patterns in aging-related pathways.
Research history
Decades of peer-reviewed research. Topical studies demonstrate wrinkle reduction, improved skin firmness, reduced skin damage from UV, and hair growth promotion in androgenetic alopecia models. Landmark studies include the Pickart lab's work across the 1980s-2000s characterizing the molecular biology, and more recent dermatology trials testing topical GHK-Cu serums and hair tonics. Animal models extend the evidence to wound healing, ischemic tissue repair, and chronic wound closure. Injectable GHK-Cu for tissue repair has less clinical evidence than topical applications.
Current trial status
Topical GHK-Cu cosmetic products are on the market broadly (The Ordinary Buffet+ Copper Peptides 1%, Niod Copper Amino Isolate Serum, various hair tonics). Clinical research continues on new delivery systems and combinations. Injectable research is limited and largely preclinical.
Regulatory status
Topical cosmetic use is permitted under FDA cosmetic regulation. Injectable GHK-Cu is on the FDA Category 2 list as of September 2023 with a February 2026 HHS proposal to remove. Topical GHK-Cu products must comply with cosmetic labeling; products making drug-level claims (e.g., 'treats wrinkles' rather than 'reduces the appearance of wrinkles') would cross into drug-regulatory territory. Full regulatory timeline →
Controversies and open questions
The core tension is evidence quality across applications. Topical GHK-Cu for skin appearance has robust support. Injectable GHK-Cu for systemic anti-aging or longevity claims has minimal human evidence; those claims in biohacker marketing outrun the research. Topical hair-growth claims sit between these — decent preclinical support, modest clinical trial evidence, and a market that's outpaced the data. The copper toxicity risk with chronic high-dose exposure has been raised but not substantiated in topical-dose human data.
Further reading
Frequently asked
Is GHK-Cu safe to use topically?
Generally yes, at cosmetic concentrations. Decades of dermatology research and broad cosmetic-product use support safety. Reported adverse effects are uncommon and mild (occasional irritation, photosensitivity at high concentrations).
Does topical GHK-Cu actually do anything?
The evidence is moderate — better than most cosmetic peptide claims. Peer-reviewed studies show measurable improvements in wrinkle depth, skin firmness, and hair-follicle stimulation. The effect size is real but not dramatic.
What about injectable GHK-Cu for anti-aging?
Injectable GHK-Cu is FDA Category 2 — cannot be legally compounded in the US. Human clinical evidence for systemic anti-aging or longevity claims is minimal despite enthusiastic biohacker marketing. Most claims extrapolate from animal models and mechanistic studies.
Which products have real GHK-Cu in useful concentrations?
The Ordinary Copper Peptides 1%, NIOD Copper Amino Isolate Serum, and a handful of hair serums list GHK-Cu at active concentrations. Many products include it at token amounts for marketing. Check the ingredient list position — it should appear in the first half, not near the preservative.
Can I use GHK-Cu with retinoids or vitamin C?
GHK-Cu is generally compatible with retinoids (use at different times of day). Vitamin C is more complex — some evidence suggests ascorbic acid can reduce copper-peptide stability in solution. Best practice: apply them on different days or in different routines.